| Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers–a systematic review of in vitro data S Doktorovova, EB Souto, AM Silva European Journal of Pharmaceutics and Biopharmaceutics 87 (1), 1-18, 2014 | 410 | 2014 |
| Development and evaluation of lipid nanocarriers for quercetin delivery: A comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid … NP Aditya, AS Macedo, S Doktorovova, EB Souto, S Kim, PS Chang, S Ko LWT-Food Science and Technology 59 (1), 115-121, 2014 | 303 | 2014 |
| Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation S Doktorovová, AB Kovačević, ML Garcia, EB Souto European Journal of Pharmaceutics and Biopharmaceutics 108, 235-252, 2016 | 253 | 2016 |
| Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review S Doktorovova, EB Souto Expert opinion on drug delivery 6 (2), 165-176, 2009 | 183 | 2009 |
| Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC) S Doktorovová, J Araújo, ML Garcia, E Rakovský, EB Souto Colloids and Surfaces B: Biointerfaces 75 (2), 538-542, 2010 | 178 | 2010 |
| Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs EB Souto, S Doktorovova, E Gonzalez-Mira, MA Egea, ML Garcia Current eye research 35 (7), 537-552, 2010 | 173 | 2010 |
| Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies T Andreani, CP Kiill, ALR de Souza, JF Fangueiro, L Fernandes, ... Colloids and Surfaces B: Biointerfaces 123, 916-923, 2014 | 117 | 2014 |
| Cationic surfactants: Self-assembly, structure-activity correlation and their biological applications LY Zakharova, TN Pashirova, S Doktorovova, AR Fernandes, ... Internathional Journal of Molecular Sciences 20 (22), 5534, 2019 | 115 | 2019 |
| Chapter Six-Solid Lipid Nanoparticle Formulations: Pharmacokinetic and Biopharmaceutical Aspects in Drug Delivery EB Souto, S Doktorovová Methods in enzymology 464, 105-129, 2009 | 111 | 2009 |
| Cationic solid lipid nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells S Doktorovová, DL Santos, I Costa, T Andreani, EB Souto, AM Silva International journal of pharmaceutics 471 (1-2), 18-27, 2014 | 79 | 2014 |
| Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies S Doktorovova, R Shegokar, E Rakovsky, E Gonzalez-Mira, CM Lopes, ... International journal of pharmaceutics 420 (2), 341-349, 2011 | 76 | 2011 |
| Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN) S Doktorovova, R Shegokar, P Martins-Lopes, AM Silva, CM Lopes, ... European Journal of Pharmaceutical Sciences 45 (5), 606-612, 2012 | 74 | 2012 |
| Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations EB Souto, S Doktorovova, P Boonme Journal of Drug Delivery Science and Technology 21 (1), 43-54, 2011 | 56 | 2011 |
| Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cells EB Souto, S Doktorovova, JR Campos, P Martins-Lopes, AM Silva European Journal of Pharmaceutical Sciences 128, 27-35, 2019 | 53 | 2019 |
| Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles S Doktorovova, AM Silva, I Gaivão, EB Souto, JP Teixeira, ... Journal of Applied Toxicology 34 (4), 395-403, 2014 | 52 | 2014 |
| Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 … S Doktorovova, EB Souto, AM Silva Pharmaceutical development and technology 23 (1), 96-105, 2018 | 49 | 2018 |
| Key production parameters for the development of solid lipid nanoparticles by high shear homogenization EB Souto, S Doktorovova, A Zielinska, AM Silva Pharmaceutical development and technology 24 (9), 1181-1185, 2019 | 46 | 2019 |
| EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation D Rafael, S Doktorovová, HF Florindo, P Gener, I Abasolo, S Schwartz Jr, ... Current gene therapy 15 (3), 300-312, 2015 | 43 | 2015 |
| The effects of cholesterol and β-sitosterol on the structure of saturated diacylphosphatidylcholine bilayers J Gallová, D Uhríková, N Kučerka, S Doktorovová, SS Funari, J Teixeira, ... European Biophysics Journal 40 (2), 153-163, 2011 | 38 | 2011 |
| Role of Excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs/NLCs) S Doktorovova, R Shegokar, EB Souto Nanostructures for Novel Therapy, 811-843, 2017 | 34 | 2017 |
Eliana B SoutoFaculty of Pharmacy of University of PortoEmail confirmado em ff.up.pt
